Homocysteine and ox-LDL increase endothelial thrombogenicity through distinct mechanisms, with homocysteine inducing tissue factor activity and ox-LDL upregulating ICAM-1.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for homocysteine- and ox-LDL-driven endothelial thrombogenicity; leaves open relevance to human disease.
Varon et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: